21.25USD+0.31%Mkt Cap: 2.66B USDP/E: —Last update: 2026-06-01
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the trea…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.66B USD
Enterprise Value2.57B USD
Revenue (TTM)415.62M USD
Gross Profit339.38M USD
Net Income (TTM)-16.14M USD
Revenue/Share3.245 USD
Last Price21.25 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees354
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)18.57
PEG—
EV/EBITDA471.35
EV/Revenue6.20
P/S6.46
P/B14.15
EPS (TTM)-0.02
EPS (Forward)1.16
52W Range
12.7245% of range31.77
52W High31.77 USD
52W Low12.72 USD
Profitability
Gross Margin90.24%
Oper. Margin-8.62%
EBITDA Margin1.31%
Profit Margin-4.29%
ROE-8.52%
ROA-3.73%
Growth
Revenue Growth60.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.63M USD
CapEx (TTM)10.69M USD
FCF Margin0.85%
FCF Yield0.13%
Net Debt-109.33M USD
Net Debt/EBITDA-20.01
Balance Sheet
Debt/Equity0.60
Current Ratio2.68
Quick Ratio2.26
Book Value/Sh1.517 USD
Cash/Share1.791 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)34.63 USD
Target Range33.00 USD – 36.00 USD
# Analysts8
Ownership
Shares Out.125.08M
Float92.59M
Insiders1.76%
Institutions109.97%
Short Interest
Short Ratio10.4d
Short % Float14.96%
Short % Out.14.03%
Shares Short17.55M
Short (prev mo.)16.58M
Technical
SMA 5022.63 (-6.1%)
SMA 20023.44 (-9.3%)
Beta1.59
S&P 52W Chg27.94%
Avg Vol (30d)1.70M
Avg Vol (10d)1.94M
Technical Indicators
RSI (14)45.6
MACD-0.5088
MACD Signal-0.6403
MACD Hist.+0.1314
BB Upper23.95 USD
BB Middle21.53 USD
BB Lower19.10 USD
BB Width22.55%
ATR (14)1.046 USD
Vol Ratio (20d)0.33x